Target intelligence / Profile preview

Intestinal epithelial cell mucin glycoprotein (primarily Mucin 2 [MUC2]) (MUC2)

Target
MUC2
Molecular classification
Other (Mucin glycoproteins: secreted and cell surface O-glycosylated proteins), Not a receptor, enzyme, transporter, or classical drug target
01

Overview

Intestinal epithelial cell mucin glycoproteins—chiefly Mucin 2 (MUC2)—are large, heavily O-glycosylated proteins secreted primarily by goblet cells in the intestinal tract. Mucins form the mucus layer, a dynamic gel that constitutes a physical and chemical barrier protecting the epithelial lining from pathogens and commensal microbes, mediating immune responses, and helping maintain gut homeostasis. The mucus barrier is organized into a dense inner layer, largely sterile and attached to the epithelium, and a looser outer layer colonized by bacteria. Disruptions in mucin production or structure are implicated in gastrointestinal diseases such as inflammatory bowel disease, increased susceptibility to infection, and disturbance of the gut microbiota. Mucins are not classical drug targets, but their regulation is central to intestinal health and disease pathogenesis.

Other names
Mucosal mucinsMucin 2 (MUC2)Intestinal mucus glycoproteinTrefoil factor 3 (TFF3)
02

Biological functions

Barrier function / Mucosal defenseImmune response (innate immunity mediation)Pathogen exclusion / microbial segregationStructural support for epithelial integrity
03

Disease associations

Inflammation (e.g., IBD, ulcerative colitis, Crohn's disease)Infection (reduced mucus increases risk)Other (wound repair, dysbiosis linkage, barrier disruption in GI disorders)
04

Safety considerations

Mucus barrier disruption can increase infection risk and inflammationOverproduction in disease can complicate gut function (rare; seen with goblet cell hyperplasia)
05

Biomarkers

MUC2 expression (biomarker for mucus barrier integrity)Mucus layer thickness (indicator for disease status in IBD)

Beyond the preview

Go deeper on Intestinal epithelial cell mucin glycoprotein (primarily Mucin 2 [MUC2]) (MUC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial cell mucin glycoprotein (primarily Mucin 2 [MUC2]) (MUC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call